Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Onconetix, Inc. Director's Dealing 2022

Feb 18, 2022

35411_dirs_2022-02-17_246c11bc-8df5-4731-82f7-183f36c92de9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-02-17

Reporting Person: Rice John McCune Jr. (Director)